These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17596525)

  • 1. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy.
    Tan Y; Keum JS; Wang B; McHenry MB; Lipsitz SR; Jaffa AA
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1026-35. PubMed ID: 17596525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Tan Y; Wang B; Keum JS; Jaffa AA
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes.
    Jaffa MA; Kobeissy F; Al Hariri M; Chalhoub H; Eid A; Ziyadeh FN; Jaffa AA
    PLoS One; 2012; 7(9):e44714. PubMed ID: 23028588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
    Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy.
    Park JK; Ronkina N; Höft A; Prohl C; Menne J; Gaestel M; Haller H; Meier M
    Nephrol Dial Transplant; 2008 Jun; 23(6):1844-53. PubMed ID: 18182404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
    Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H
    Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
    J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of growth arrest-specific gene 6 in diabetic nephropathy.
    Arai H; Nagai K; Doi T
    Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model.
    Buléon M; Allard J; Jaafar A; Praddaude F; Dickson Z; Ranera MT; Pecher C; Girolami JP; Tack I
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1249-56. PubMed ID: 18367657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.
    Hamada Y; Miyata S; Nii-Kono T; Kitazawa R; Kitazawa S; Higo S; Fukunaga M; Ueyama S; Nakamura H; Yodoi J; Fukagawa M; Kasuga M
    Nephrol Dial Transplant; 2007 Jun; 22(6):1547-57. PubMed ID: 17360766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats.
    Allard J; Buléon M; Cellier E; Renaud I; Pecher C; Praddaude F; Conti M; Tack I; Girolami JP
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1083-92. PubMed ID: 17596523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
    Ohshiro Y; Ma RC; Yasuda Y; Hiraoka-Yamamoto J; Clermont AC; Isshiki K; Yagi K; Arikawa E; Kern TS; King GL
    Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.